IntelGenx Technologies Corp. Share Price OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2022 | 950K 1.3M 74.97M | Sales 2023 | 1.04M 1.42M 81.99M | Capitalization | 24.12M 33M 1.9B |
---|---|---|---|---|---|
Net income 2022 | -10M -13.68M -789M | Net income 2023 | -9M -12.31M -710M | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 7.98M 10.92M 630M | Net Debt 2023 | 13.22M 18.08M 1.04B | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 12/04/23 |
André Godin
DFI | Director of Finance/CFO | 61 | 19/07/15 |
Horst Zerbe
CHM | Chairman | 77 | 31/03/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 31/03/06 |
Mark Nawacki
BRD | Director/Board Member | 54 | 08/08/16 |
Bernd Melchers
BRD | Director/Board Member | 72 | 07/04/09 |
1st Jan change | Capi. | |
---|---|---|
+20.27% | 43.77B | |
+30.16% | 22.83B | |
+20.07% | 15.56B | |
+18.55% | 14.34B | |
+54.87% | 12.96B | |
-0.05% | 6.79B | |
-11.72% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock